LifeStance Health Group, Inc. - Common Stock (LFST)
6.4400
+0.2600 (4.21%)
NASDAQ · Last Trade: Nov 21st, 11:26 PM EST
Detailed Quote
Previous Close
6.180
Open
6.170
Bid
6.450
Ask
6.600
Day's Range
6.090 - 6.506
52 Week Range
3.740 - 8.295
Volume
1,960,720
Market Cap
2.43B
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
2,293,669
Chart
About LifeStance Health Group, Inc. - Common Stock (LFST)
Lifestance Health Group Inc is a prominent provider of mental health services that focuses on delivering high-quality behavioral health care to individuals seeking support for various mental health issues. The company operates a network of mental health professionals, including psychiatrists, psychologists, and therapists, who offer a range of services such as therapy, medication management, and telehealth consultations. Committed to improving access to mental health care, Lifestance Health emphasizes a patient-centered approach and leverages technology to enhance the therapeutic experience, making mental health services more accessible and convenient for patients across the United States. Read More
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
LifeStance Health Group trades at $6.18 per share and has stayed right on track with the overall market, gaining 8.9% over the last six months. At the same time, the S&P 500 has returned 13.7%.
LifeStance Health's third quarter results drew a strongly positive market reaction, reflecting management’s focus on clinician productivity and operational efficiency. CEO David Bourdon attributed the company’s performance to record organic visit growth, driven by both increased clinician hiring and improved productivity. Initiatives such as the Cash Incentive Program and new technology platforms helped boost patient acquisition and clinician engagement. Bourdon emphasized that the hybrid model of in-person and virtual care, as well as a focus on commercial insurance, provided stability amid broader industry changes.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently -
over the past six months, the collective 10.9% gain for healthcare stocks has fallen short of the S&P 500’s 16.4% rise.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Behavioral health company LifeStance Health (NASDAQ:LFST) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 16.3% year on year to $363.8 million. The company expects next quarter’s revenue to be around $378 million, close to analysts’ estimates. Its GAAP profit of $0 per share was $0.01 above analysts’ consensus estimates.
Behavioral health company LifeStance Health (NASDAQ:LFST) announced better-than-expected revenue in Q3 CY2025, with sales up 16.3% year on year to $363.8 million. The company expects next quarter’s revenue to be around $378 million, close to analysts’ estimates. Its GAAP loss of $0 per share was in line with analysts’ consensus estimates.
SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2025.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming UBS Global Healthcare Conference, which will be hosted in Palm Beach Gardens, FL.
SCOTTSDALE, Ariz., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its third quarter 2025 earnings release before the market opens on Thursday, November 6, 2025.
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Looking back on outpatient & specialty care stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including LifeStance Health Group (NASDAQ:LFST) and its peers.
Shares of behavioral health company LifeStance Health (NASDAQ:LFST)
fell 5.6% in the afternoon session after the company detailed operational challenges at a recent investor conference.
Great things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently -
over the past six months, healthcare stocks were flat while the S&P 500 was up 11.6%.
SCOTTSDALE, Ariz., Aug. 26, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 23rd Annual Morgan Stanley Global Healthcare Conference, which will be hosted in New York City, NY.
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match.
The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth-oriented sectors like healthcare, as they reduce the cost of borrowing for research and innovation and increase the present value of future earnings.
